Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Clinical Trial of Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer

NCT04887935 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04887935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04887935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Clinical Trial of Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Terminated
Start date
June 4, 2024
Completion date
November 26, 2025
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of prostate, prostate cancer